PRIMARY INFORMATION |
---|
ID | 1403 |
PMID | 1144451 |
Year | 1975 |
Sequence | (Chain A: GIVEQCCTSICSLYQLENYCN) (Chain B: FVNQHLCGSHLVEALYLVCGERGFFYTPKT) |
Name | Insulin |
Length | 51 |
N-Terminal Modification | Free |
C-Terminal Modification | Free |
Linear/ Cyclic | Cyclic (Chain A: C6-C11)(Chain A:C7-Chain B:C7) (Chain A:C20-Chain B:C19) |
Chirality | L |
Chemical Modification | None |
Origin of Peptide | Synthetic (USP Lilly Iletin 80 U/cc) |
Nature of Peptide/Cargo | Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. |
Mechanism | Synthetic (USP Lilly Iletin 80 U/cc) |
Cargo Sequence/Structure | None |
Name of cargo
| Not applicable |
Assay | Chloride in the sweat determined by titration with a Cotiove chloridometer |
Enhancer | Pilocarpine iontophoresis |
Properties of enhancer | Not mentioned |
Concentration | 80 U/cc |
Incubation time | 10 minutes iontophoresis followed by 30 minutes collection |
Tissue permeability (value with units) | Control/Cystic fibrosis patients: 14.81±2.39/16.03±2.34(Vehicle treated) and 14.47±2.66/11.52±1.28(Insulin treated) |
Tissue Sample | Stratum corneum of arm of cystic fibrosis patients |
Ex vivo/In vivo/In vitro | in vivo |
SECONDARY INFORMATION |
---|
STRUCTURE | |
SMILES | N.A. |